Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 14;23(6):64.
doi: 10.1007/s11912-021-01059-1.

Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building

Affiliations
Review

Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building

Diego Sadler et al. Curr Oncol Rep. .

Abstract

Purpose of review: This study aims to assess the current state of cardio-oncology in reference to advocacy efforts, access to care, and perspective of stakeholders in their ability to provide patient care as well as development of "across the aisle" synergy among cardiologists and oncologists and academic and non-academic centers in various worldwide locations.

Recent findings: During the last decade, there has been a significant and diverse growth in cardio-oncology. We reviewed the experience from cardiologists and oncologists across different healthcare systems, the global trends, the role of collaborative networks, and the importance of advocacy efforts. Cardio-oncology will continue to grow, but there is an unmet need to increase awareness, improve education, and expand access to care to larger segments of the cancer population in order to have a more significant impact on their health. The growing collaboration through professional societies and collaborative networks provides an opportunity to advance the cardiovascular care of cancer patients to meet the projected needs in a growing and more diverse population.

Keywords: Advocacy; Cardio-oncology; Healthcare.

PubMed Disclaimer

Conflict of interest statement

Diego Sadler, Anita Arnold, Joerg Herrmann, Andres Daniele, Carolina Maria Pinto Domingues Carvalho Silva, Arjun K. Ghosh, Roohi Ismail-Khan, Luis Raez, Anne Blaes, and Sherry-Ann Brown declare no conflict of interest. Sebastian Szmit has received clinical trial funding from Bristol-Myers Squibb and Pfizer for the CARAVAGGIO trial and the API-CAT study; has received compensation from Clinigen Group for participation on a multinational European Union advisory board; and has received compensation for service as a consultant from Amgen, Angelini, AstraZeneca, Bayer, Berlin-Chemie AG, Bristol-Myers Squibb, Janssen-Cilag, Pfizer, Roche, and TEVA.

Figures

Fig. 1
Fig. 1
This figure describes the collaborative partnership between cardiologists and oncologists initiated in the state of Florida and expanded to form a national and international advocacy network
Fig. 2
Fig. 2
This figure illustrates the interaction between stakeholders in cardio-oncology and the collaborations needed to occur among physicians, professional medical associations, academic and community centers/practices, and collaborative networks to expand education, awareness, and access to care in cardio-oncology. ICOS, International Cardio-Oncology Society

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. doi: 10.3322/caac.21442. - DOI - PubMed
    1. Herrmann J. From trends to transformation: where cardio-oncology is to make a difference. Eur Heart J. 2019;40:3898–3900. doi: 10.1093/eurheartj/ehz781. - DOI - PubMed
    1. Sturgeon KN, Deng L, Bluethman SL, et al. A population based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40:3889–3897. doi: 10.1093/eurheartj/ehz766. - DOI - PMC - PubMed
    1. Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “Silver Tsunami”. Cancer Epidemiol Biomark Prev. 2016;25:1029–1036. doi: 10.1158/1055-9965.EPI-16-0133. - DOI - PMC - PubMed
    1. Fradley MG, Brown AC, Shields B, et al. Developing a comprehensive cardio-oncology program at a cancer institute: the Moffitt experience. Oncol Rev. 2017;11:340. - PMC - PubMed

LinkOut - more resources